Delivery Order SPE2DX22D0010-SPE2D826FCG28
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $74,044.06 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside, competitively awarded contract represents a single delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The work will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $34,593.82 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 7, 2026, valued at $21,483.00 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-set-aside award is scheduled for completion by January 8, 2026, with performance occurring at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order execution under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $6,156.96 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $93,276.40 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with no set-aside, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCG28Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,679.16 by the Defense Logistics Agency (DLA) Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor based in Conshohocken, Pennsylvania. The contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The DLA Medical Supply Chain relies on Amerisourcebergen's extensive pharmaceutical distribution capabilities to supply critical medical commodities to military treatment facilities, veterans' healthcare systems, and other federal medical institutions. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen maintains a diverse portfolio of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains. This delivery order exemplifies the company's role as a key vendor in federal medical procurement, fulfilling the Department of Defense's ongoing need for reliable and efficient pharmaceutical supply chain support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/6/26 |